We are not interested in trend-based upselling
After consideration of these public comments, we are finalizing our proposal, without modification, to continue our current policy of utilizing a budget neutral 7.1 percent payment adjustment for rural SCHs, including EACHs, for all services and procedures paid under the OPPS, excluding separately payable drugs and biologicals, brachytherapy sources, devices paid under the pass-through payment policy, and items paid at charges reduced to costs
Further research required before therapeutic application
Your biology is yours, so protect it and optimize by any means necessary
We are looking at billing Q4177 (Amnio) with 96372
Practices billing Medicaid should verify rates through their states Medicaid fee schedule rather than relying on the MPFS as a proxy